These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 18374637)

  • 21. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
    ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
    J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
    Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
    Dijkstra G; Moshage H; van Dullemen HM; de Jager-Krikken A; Tiebosch AT; Kleibeuker JH; Jansen PL; van Goor H
    J Pathol; 1998 Dec; 186(4):416-21. PubMed ID: 10209492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations.
    Sipos F; Molnár B; Zágoni T; Berczi L; Tulassay Z
    Dis Colon Rectum; 2005 Apr; 48(4):775-86. PubMed ID: 15747078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozbilgin K; Yuksel H; Bayrak P; Unlu H; Giray G; Kiliccioglu B
    Eur Cytokine Netw; 2004; 15(4):317-22. PubMed ID: 15627640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, localization and systemic concentration of vascular endothelial growth factor (VEGF) and its receptors in patients with ulcerative colitis.
    Frysz-Naglak D; Fryc B; Klimacka-Nawrot E; Mazurek U; Suchecka W; Kajor M; Kurek J; Stadnicki A
    Int Immunopharmacol; 2011 Feb; 11(2):220-5. PubMed ID: 21115119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.
    Mazzucchelli L; Hauser C; Zgraggen K; Wagner HE; Hess MW; Laissue JA; Mueller C
    J Pathol; 1996 Feb; 178(2):201-6. PubMed ID: 8683390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease.
    Beddy D; Watson RW; Fitzpatrick JM; O'Connell PR
    Br J Surg; 2004 Jan; 91(1):72-7. PubMed ID: 14716797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.